1.
Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7. Assumptions
and Limitations
3.
Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, and Trends
4.
Voice of Customer
5. Global
Long-Acting Drug Delivery Technologies and Services Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Technique (Injectables, Hydrogels, Implants,
Microneedles, Nanocrystal Suspensions)
5.2.2.
By Dosage Forms (Long-acting Injectables, Long-acting
Implantable, Topical / Transdermal, Vaginal, Other)
5.2.3.
By Material Used (Polymer based, Non-polymer based)
5.2.4.
By Distribution Channels (Hospitals and Retail
Pharmacies, Research and Academics, Others)
5.2.5.
By Company (2023)
5.2.6.
By Region
5.3.
Market Map
6. North
America Long-Acting Drug Delivery Technologies and Services Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By
Technique
6.2.2. By
Dosage Forms
6.2.3. By
Material Used
6.2.4. By
Distribution Channels
6.2.5.
By Country
6.3.
North America: Country Analysis
6.3.1.
United States Long-Acting Drug Delivery Technologies
and Services Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Technique
6.3.1.2.2.
By Dosage Forms
6.3.1.2.3.
By Material Used
6.3.1.2.4.
By Distribution Channels
6.3.2.
Mexico Long-Acting Drug Delivery Technologies and
Services Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Technique
6.3.2.2.2.
By Dosage Forms
6.3.2.2.3.
By Material Used
6.3.2.2.4.
By Distribution Channels
6.3.3.
Canada Long-Acting Drug Delivery Technologies and
Services Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Technique
6.3.3.2.2.
By Dosage Forms
6.3.3.2.3.
By Material Used
6.3.3.2.4.
By Distribution Channels
7. Europe
Long-Acting Drug Delivery Technologies and Services Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By
Technique
7.2.2.
By Dosage Forms
7.2.3. By
Material Used
7.2.4. By
Distribution Channels
7.2.5.
By Country
7.3.
Europe: Country Analysis
7.3.1.
France Long-Acting Drug Delivery Technologies and
Services Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Technique
7.3.1.2.2.
By Dosage Forms
7.3.1.2.3.
By Material Used
7.3.1.2.4.
By Distribution Channels
7.3.2.
Germany Long-Acting Drug Delivery Technologies and
Services Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Technique
7.3.2.2.2.
By Dosage Forms
7.3.2.2.3.
By Material Used
7.3.2.2.4.
By Distribution Channels
7.3.3.
United Kingdom Long-Acting Drug Delivery Technologies
and Services Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Technique
7.3.3.2.2.
By Dosage Forms
7.3.3.2.3.
By Material Used
7.3.3.2.4.
By Distribution Channels
7.3.4.
Italy Long-Acting Drug Delivery Technologies and
Services Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Technique
7.3.4.2.2.
By Dosage Forms
7.3.4.2.3.
By Material Used
7.3.4.2.4.
By Distribution Channels
7.3.5.
Spain Long-Acting Drug Delivery Technologies and
Services Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Technique
7.3.5.2.2.
By Dosage Forms
7.3.5.2.3.
By Material Used
7.3.5.2.4.
By Distribution Channels
8. Asia-Pacific
Long-Acting Drug Delivery Technologies and Services Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By
Technique
8.2.2. By
Dosage Forms
8.2.3. By
Material Used
8.2.4. By
Distribution Channels
8.2.5.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1.
China Long-Acting Drug Delivery Technologies and
Services Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Technique
8.3.1.2.2.
By Dosage Forms
8.3.1.2.3.
By Material Used
8.3.1.2.4.
By Distribution Channels
8.3.2.
India Long-Acting Drug Delivery Technologies and
Services Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Technique
8.3.2.2.2.
By Dosage Forms
8.3.2.2.3.
By Material Used
8.3.2.2.4.
By Distribution Channels
8.3.3.
South Korea Long-Acting Drug Delivery Technologies and
Services Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Technique
8.3.3.2.2.
By Dosage Forms
8.3.3.2.3.
By Material Used
8.3.3.2.4.
By Distribution Channels
8.3.4.
Japan Long-Acting Drug Delivery Technologies and
Services Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Technique
8.3.4.2.2.
By Dosage Forms
8.3.4.2.3.
By Material Used
8.3.4.2.4.
By Distribution Channels
8.3.5.
Australia Long-Acting Drug Delivery Technologies and
Services Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Technique
8.3.5.2.2.
By Dosage Forms
8.3.5.2.3.
By Material Used
8.3.5.2.4.
By Distribution Channels
9. South
America Long-Acting Drug Delivery Technologies and Services Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By
Technique
9.2.2.
By Dosage Forms
9.2.3. By
Material Used
9.2.4. By
Distribution Channels
9.2.5.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Long-Acting Drug Delivery Technologies and
Services Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Technique
9.3.1.2.2.
By Dosage Forms
9.3.1.2.3.
By Material Used
9.3.1.2.4.
By Distribution Channels
9.3.2.
Argentina Long-Acting Drug Delivery Technologies and
Services Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Technique
9.3.2.2.2.
By Dosage Forms
9.3.2.2.3.
By Material Used
9.3.2.2.4.
By Distribution Channels
9.3.3.
Colombia Long-Acting Drug Delivery Technologies and
Services Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Technique
9.3.3.2.2.
By Dosage Forms
9.3.3.2.3.
By Material Used
9.3.3.2.4.
By Distribution Channels
10. Middle
East and Africa Long-Acting Drug Delivery Technologies and Services Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By
Technique
10.2.2.
By Dosage Forms
10.2.3. By
Material Used
10.2.4. By
Distribution Channels
10.2.5.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Long-Acting Drug Delivery Technologies
and Services Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Technique
10.3.1.2.2.
By Dosage Forms
10.3.1.2.3.
By Material Used
10.3.1.2.4.
By Distribution Channels
10.3.2.
Saudi Arabia Long-Acting Drug Delivery Technologies
and Services Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Technique
10.3.2.2.2.
By Dosage Forms
10.3.2.2.3.
By Material Used
10.3.2.2.4.
By Distribution Channels
10.3.3.
UAE Long-Acting Drug Delivery Technologies and
Services Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Technique
10.3.3.2.2.
By Dosage Forms
10.3.3.2.3.
By Material Used
10.3.3.2.4.
By Distribution Channels
10.3.4.
Egypt Long-Acting Drug Delivery Technologies and
Services Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Technique
10.3.4.2.2.
By Dosage Forms
10.3.4.2.3.
By Material Used
10.3.4.2.4.
By Distribution Channels
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Merger & Acquisition (If Any)
12.2.
Product Launches (If Any)
12.3.
Recent Developments
13.
Porters Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14.
Competitive Landscape
14.1.
Adare Pharma Solutions
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT Analysis
14.2.
Alkermes plc
14.3.
Camurus AB
14.4.
Corium, LLC.
14.5.
Creative Biolabs, Inc.
14.6.
Delpor, Inc.
14.7.
Durect Corporation
14.8.
Hanmi Pharm.Co.,Ltd.
14.9.
Integrated Bio Systems, Inc.
14.10.
Heron Therapeutics, Inc.
15.
Strategic Recommendations
16.
About Us & Disclaimer